The summer of 2019 saw a record 16 Gateways students. They came from across the country to spend 10 weeks working in labs at all three of our institutions (plus one at HSS), doing clinical shadowing, participating in clinical problem based lab discussions led by current MD-PhD students, and volunteering in the Heart to Heart Community Clinic.
With another three interview days behind us (two in October and the last one just recently on November 21), we are waist deep in the 2020 admissions cycle. With 90 applicants representing 43 colleges and universities invited to interview over the three days, it has been an exciting interview season here at the Tri-I. We were honored to welcome this multi-talented group of students to our campus.
A total of ten Gateways alumni presented their research at the 2019 Annual Biomedicine Research Conference for Minority Students (ABRCMS). Held from November 13th through the 16th in Anaheim, California, the conference saw attendance of more than 5,000 undergraduates, graduate students, and researchers.
In a study published in Nature on October 23, Conor Liston, MD, PhD, and his collaborators present new results, using mouse models, on the effects of depleted gut microbiota on the brain.
Dr. Randy Longman, MD, PhD, (Tri-I MD-PhD graduating class of 2007) has been named as the new Director of the Jill Roberts Center for Inflammator Bowel Disease at Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center.
Preethi Periyakoil, Tri-I MD-PhD incoming class of 2019, has been named one of two recipients of the Milton and Rosalind Chang Career Exploration Prize from CalTech, given to alumni of that institution, from which institution she earned her BS in Computer Science in 2018.Ms. Periyakoil received the Chang Prize for her proposed project “University Support Text Line" along side one other honoree.
José Trevejo, MD, PhD, (Tri-I graduating class of 2001), was interviewed by the Massachusetts Biotechnology Council on his background, career, education, and the need for more Hispanic and Latino/a in STEM fields and biotech, particularly in leadership positions.Dr. Trevejo is currently the CEO and Co-FOunder of Smartpharm Therapeutics in Boston.
Dr. Ronald Koenig, Tri-Instutional MD-PhD graduating class 1978, has been selected to receive the Lifetime Achievement Award in Medical Education from Michigan Medicine, where he has been a member of the faculty since 1988 and the director of their MSTP since 1995.
Sofia Gearty, fifth year student in the Tri-Institutional MD-PhD Program, has been awarded an F-30 Fellowship from the NIH's National Institute of Diabetes and Digestive Kidney Diseases for her project T cell Heterogeneity and Fate Diversification in Autoimmune Type I Diabetes.